Hundreds of laid-off CDC employees can return to work. But some won't be back

Hundreds of Centers for Disease Control and Prevention employees are being allowed to return to work as of Wednesday.
A fired CDC employee says she's happy for them, but she feels confused by the whole situation.
'It was always my dream to serve the public,' said Sarah Boim.
She told Channel 2's Bryan Mims she worked as a health communications specialist for the Centers for Disease Control and Prevention for one year before she went on paid administrative leave in February.
The government terminated her in May.
Boim helped found Fired But Fighting, an organization working to have all CDC employees rehired and to remove Robert F. Kennedy as Health and Human Services secretary.
She said she's grateful hundreds of laid-off employees can go back to their jobs at the CDC.
'I'm so happy for them, but I'm also a little confused because the government decided these people were doing critical work,' Boim said.
She said these 460-plus employees couldn't do their critical work for more than 70 days.
The U.S. Dept. of Health and Human Services confirmed that notices went out Wednesday to these 460 or so workers, saying they could return to the CDC.
In April, about 2,400 CDC employees were laid off, about 18% of the CDC's staff.
RELATED STORIES:
Hundreds of laid-off CDC employees are being reinstated
Protesters rally outside CDC offices in DeKalb County after advisory committee fired
CDC official who oversaw COVID-19 vaccine recommendations has resigned following HHS rollback
The Department of Health and Human Services confirms these rehired employees are part of four divisions. They include the National Center for HIV, Viral Hepatitis, STD and Tuberculosis Prevention.
Employees reinstated also include lab scientists who track lead poisoning.
'For every public health position that's lost, lives are at risk. So, multiply that by 2,000 just here at CDC. And you can see that we're really in a dire situation,' Boim said.
[SIGN UP: WSB-TV Daily Headlines Newsletter]
Andrew Nixon, Health and Human Services spokesperson, responded with a written statement, saying the nation's critical health functions remain intact.
'HHS is streamlining operations without compromising mission-critical work. Enhancing the health and well-being of all Americans remains our top priority,' the statement said.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Washington Post

28 minutes ago

• Washington Post

US measles count now tops 1,200 cases, and Iowa announces an outbreak

The U.S. logged fewer than 20 measles cases this week, though Iowa announced the state's first outbreak Thursday and Georgia confirmed its second Wednesday. There have been 1,214 confirmed measles cases this year, the Centers for Disease Control and Prevention said Friday. Health officials in Texas, where the nation's biggest outbreak raged during the late winter and spring, confirmed six cases in the last week.

Yahoo

32 minutes ago

• Yahoo

CureVac Soars 41% in a Month on a $1.25B Buyout Offer From BioNTech

Shares of CureVac N.V. CVAC have skyrocketed 40.8% in a month after the company signed a definitive agreement to be acquired by BioNTech SE BNTX in an all-stock transaction last week. Per the agreement, each CVAC share will be exchanged for approximately $5.46 worth of BNTX American Depositary Shares (ADS), implying a total equity value of around $1.25 billion for CureVac. The consideration per ADS represents a premium of 55% to CVAC's three-month volume-weighted average price of approximately $3.53 as of June 11, 2025. Subject to the closing of the transaction, CureVac shareholders are expected to own between 4% and 6% of BioNTech. The closing of the transaction, expected in 2025, is based on the fulfillment of certain customary closing conditions and required regulatory approvals. Year to date, shares of CureVac have surged 61% against the industry's 4.8% decline. Image Source: Zacks Investment Research The acquisition of CureVac will help BioNTech enhance its capabilities in advancing investigational mRNA-based cancer immunotherapies by expanding its research, development, manufacturing and commercialization infrastructure. It complements BioNTech's existing strengths in mRNA design, delivery technologies and production. BNTX's Comirnaty is the first approved mRNA-based vaccine for COVID-19, which was developed in collaboration with Pfizer. Strategically, the deal will allow BioNTech to expand beyond its existing oncology pipeline and focus on its newer programs across several tumor types, including key assets like its mRNA-based cancer candidates and BNT327, a PD-L1xVEGF-A bispecific antibody. We remind the investors that earlier in June, BioNTech signed a strategic collaboration agreement with Bristol Myers BMY for the global co-development and co-commercialization of BNTX's BNT327, as monotherapy and in combinations, across numerous solid tumor types. BMY will pay $1.5 billion upfront, with $2 billion in additional payments through 2028 and up to $7.6 billion in milestones. BioNTech and Bristol Myers will equally share costs and profits. BNT327 is in late-stage, potentially registrational clinical studies for two different lung cancer indications. Another phase III study evaluating the candidate in triple-negative breast cancer is planned to start by the end of 2025. Early data show promising synergy in targeting two key cancer pathways. CureVac N.V. price-consensus-chart | CureVac N.V. Quote CureVac currently carries a Zacks Rank #3 (Hold). A better-ranked stock in the biotech sector is Immunocore IMCR, currently sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks #1 Rank stocks here. In the past 60 days, loss per share estimates for Immunocore's 2025 have improved from $1.50 to 86 cents. Loss per share estimates for 2026 have narrowed from $1.68 to $1.33 during the same period. IMCR stock has gained 7.5% year to date. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Bristol Myers Squibb Company (BMY) : Free Stock Analysis Report BioNTech SE Sponsored ADR (BNTX) : Free Stock Analysis Report CureVac N.V. (CVAC) : Free Stock Analysis Report Immunocore Holdings PLC Sponsored ADR (IMCR) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio

Boston Globe

2 hours ago

• Boston Globe

Supreme Court finds retired firefighter cannot sue for disability discrimination

Advertisement In a dissent, Justice Ketanji Brown Jackson, joined, in part, by Justice Sonia Sotomayor, argued that the justices had abandoned protections for vulnerable retirees. Get Starting Point A guide through the most important stories of the morning, delivered Monday through Friday. Enter Email Sign Up 'Disabled Americans who have retired from the work force simply want to enjoy the fruits of their labor free from discrimination,' Jackson wrote, adding that Congress had 'plainly protected their right to do so' when it drafted the federal disability rights law. Sotomayor, in a separate writing, argued that a majority of the justices appeared in agreement that retirees may be able to bring disability discrimination claims for actions that occurred while they were still employed. Stanley might have been able to argue that this would apply in her case, too, Sotomayor wrote, but the court had not been asked to weigh in on that question. Advertisement Stanley worked as a firefighter in Sanford, Florida, a city of about 65,000 people northeast of Orlando. When she started her job in 1999, the city offered health insurance until age 65 for two categories of retirees -- those with 25 years of service and those who retired early because of disability. In 2003, the city changed its policy, limiting health insurance to those who retired because of disability to just 24 months of coverage. After nearly two decades, Stanley retired in 2018 at age 47 after she was diagnosed with Parkinson's disease. She expected that the city would continue to pay for most of her health insurance until she turned 65, but it refused, citing its changed policy. Stanley sued, claiming that the city had violated the ADA by providing different benefits to 25-year employees versus those who retired because of a disability. She argued that the city's policy amounted to impermissible discrimination based on disability. A federal trial judge dismissed her claim under the ADA, and the U.S. Court of Appeals for the 11th Circuit agreed. In asking the justices to hear the case, lawyers for Stanley said it could affect millions of disabled Americans who rely on retirement benefits that they earned while employed. One section of the ADA specifies that it is illegal to discriminate in compensation because of a disability. The justices wrestled with whether the section included retirees. Deepak Gupta, a lawyer for Stanley, said in an emailed statement that the decision had created 'a troubling loophole that allows employers to discriminate against retirees simply because they can no longer work due to their disabilities.' Advertisement In her dissent, Jackson wrote that she hoped Congress might step in and provide a 'legislative intervention' to shield other disabled retirees. This article originally appeared in